National Health Investors Reports Strong Q1: Revenue Jumps 29%, EPS Up 11%
NHI is trading near its 52-week low of $68.8 (10% above the low).
Summary
National Health Investors reported robust first-quarter 2026 results, with revenue increasing 28.9% year-over-year to $115.13 million and diluted EPS rising 10.8% to $0.82. This strong performance was driven by recent acquisitions, successful transitions to SHOP operations, and improved operator performance. The results reflect the impact of the previously announced sale of 35 skilled nursing and independent living facilities and ongoing portfolio reshaping efforts. Traders will monitor how these strategic shifts, alongside the recent CFO retirement and appointment, continue to influence future financial performance and dividend sustainability.
At the time of this announcement, NHI was trading at $75.71 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $68.80 to $91.38. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.